Onderneming Hunan Fangsheng Pharmaceutical Co., Ltd.
Aandelen
603998
CNE100001VG6
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,82 CNY | +2,07% | +2,87% | +7,85% |
19/04 | Hunan Fangsheng Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024 | CI |
10/04 | Fangsheng Pharma's fabrieken slagen voor GMP-inspectie | MT |
Vakgebied
Aantal werknemers: 1 686
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cardiovascular and Cerebrovascular Disease Medication
23,6
%
| 449 | 25,1 % | 385 | 23,6 % | -14,34% |
Musculoskeletal Systemic Drugs
22,0
%
| 368 | 20,5 % | 359 | 22,0 % | -2,34% |
Other
17,4
%
| 438 | 24,4 % | 284 | 17,4 % | -35,14% |
Medication for Children
11,6
%
| 151 | 8,4 % | 188 | 11,6 % | +24,74% |
Respiratory System Medication
11,0
%
| 140 | 7,8 % | 180 | 11,0 % | +27,96% |
Gynecological Diseases Medication
5,7
%
| 109 | 6,1 % | 92 | 5,7 % | -15,21% |
Anti-infective Drugs
5,0
%
| 96 | 5,4 % | 82 | 5,0 % | -14,98% |
Other Business
3,6
%
| 41 | 2,3 % | 59 | 3,6 % | +43,19% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 792 | 100,0 % | 1 629 | 100,0 % | -9,12% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Li Zhou
CEO | Chief Executive Officer | 51 | - |
Zai Chang Liu
DFI | Director of Finance/CFO | 50 | 17-06-21 |
43 | - | ||
Meng Gong
COO | Chief Operating Officer | 43 | - |
Bo Chen
BRD | Director/Board Member | 45 | 31-07-14 |
Bo Ru Zeng
IRC | Investor Relations Contact | 30 | - |
Shi He
SEC | Corporate Secretary | 39 | 22-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 19-09-23 |
Shou Ying Du
BRD | Director/Board Member | 64 | 01-05-20 |
Xiong Yuan
BRD | Director/Board Member | 59 | 16-11-21 |
Bo Chen
BRD | Director/Board Member | 45 | 31-07-14 |
Xiao Li Zhou
CEO | Chief Executive Officer | 51 | - |
Man Xiao
CHM | Chairman | 43 | - |
Meng Gong
COO | Chief Operating Officer | 43 | - |
Bo Ru Zeng
IRC | Investor Relations Contact | 30 | - |
Yue Xiao
BRD | Director/Board Member | 45 | 16-09-22 |
Xiang Mu Shen
BRD | Director/Board Member | 37 | 30-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 439 616 620 | 262 446 545 ( 59,70 %) | 1 145 000 ( 0,2605 %) | 59,70 % |
Bedrijfsgegevens
Hunan Fangsheng Pharmaceutical Co., Ltd.
299 Jiayun Road National High-Tech Indl Dev Zone
410205, Changsha
+
http://www.fangsheng.com.cnSector
Verkoop per activiteit
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,85% | 718 mln. | |
+19,98% | 43,48 mld. | |
+20,67% | 22,65 mld. | |
+14,56% | 14,73 mld. | |
+14,32% | 13,79 mld. | |
+44,72% | 12,04 mld. | |
-8,37% | 7,08 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+11,90% | 5,47 mld. |
- Beurs
- Aandelen
- Koers 603998
- Onderneming Hunan Fangsheng Pharmaceutical Co., Ltd.